van Sonderen, Agnes
Petit-Pedrol, Mar
Dalmau, Josep
Titulaer, Maarten J.
Article History
First Online: 18 April 2017
Competing interests
: J.D. receives royalties from patents from Athena Diagnostics for the use of Ma2 and <i>N</i>-methyl-d-aspartate receptors (NMDAR) as autoantibody tests, and licensing fees from Euroimmun for a patent for the use of NMDAR as an autoantibody test. M.J.T. received research funds for serving on a scientific advisory board of MedImmune, Guidepoint Global, and a travel grant for lecturing in India from Sun Pharma, India. The other authors declare no competing interests.